Reperfusion therapies for wake-up stroke: Systematic review

Stroke

Volumn 45, Issue 6, 2014, Pages 1869-1875

  Buck, Deborah ^a   Shaw, Lisa C ^a   Price, Christopher I ^a   Ford, Gary A ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

stroke; thrombolytic therapy; treatment outcome

Indexed keywords

ABCIXIMAB;

BRAIN HEMORRHAGE; BRAIN PERFUSION; CEREBROVASCULAR ACCIDENT; CLINICAL PROTOCOL; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DIGITAL SUBTRACTION ANGIOGRAPHY; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; WAKE UP STROKE;

STROKE; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

ANIMALS; HUMANS; REPERFUSION; STROKE; THROMBOLYTIC THERAPY;

EID: 84901940331     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.005126     Document Type: Review

References (24)

1. Fink JN, Kumar S, Horkan C, Linfante I, Selim MH, Caplan LR, et al. The stroke patient who woke up: clinical and radiological features, including diffusion and perfusion MRI. Stroke. 2002;33:988-993.
2. Nadeau JO, Fang J, Kapral MK, Silver FL, Hill MD; Registry of the Canadian Stroke Network. Outcome after stroke upon awakening. Can J Neurol Sci. 2005;32:232-236.
3. Barrett KM, Meschia JF, Barrett KM, Meschia JF. Acute ischemic stroke management: medical management. Semin Neurol. 2010;30:461-468.
4. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, et al; ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317-1329.
5. Serena J, Dávalos A, Segura T, Mostacero E, Castillo J. Stroke on awakening: looking for a more rational management. Cerebrovasc Dis. 2003;16:128-133.
6. Todo K, Moriwaki H, Saito K, Tanaka M, Oe H, Naritomi H. Early CT fndings in unknown-onset and wake-up strokes. Cerebrovasc Dis. 2006;21:367-371.
7. Iosif C, Oppenheim C, Trystram D, Domigo V, Méder JF. MR imaging-based decision in thrombolytic therapy for stroke on awakening: report of 2 cases. Am J Neuroradiol. 2008;29:1314-1316.
8. Aoki J, Kimura K, Iguchi Y, Shibazaki K, Iwanaga T, Watanabe M, et al. Intravenous thrombolysis based on diffusion-weighted imaging and fuid-attenuated inversion recovery mismatch in acute stroke patients with unknown onset time. Cerebrovasc Dis. 2011;31:435-441.
9. Kuruvilla A, Norris GM, Xavier AR. Acute endovascular recanalization therapy in wake-up stroke. J Neurol Sci. 2011;300:148-150.
10. Breuer L, Schellinger PD, Huttner HB, Halwachs R, Engelhorn T, Doerfer A, et al. Feasibility and safety of magnetic resonance imaging-based thrombolysis in patients with stroke on awakening: initial single-centre experience. Int J Stroke. 2010;5:68-73.
11. Bai Q, Zhao Z, Fu P, Sui H, Xie X, Chen J, et al. Clinical outcomes of fast MRI-based trombolysis in wake-up strokes compared to superacute ischemic strokes within 12 hours. Neurol Res. 2013;35:492-497.
12. Barreto AD, Martin-Schild S, Hallevi H, Morales MM, Abraham AT, Gonzales NR, et al. Thrombolytic therapy for patients who wake-up with stroke. Stroke. 2009;40:827-832.
13. Kang DW, Sohn SI, Hong KS, Yu KH, Hwang YH, Han MK, et al. Reperfusion therapy in unclear-onset stroke based on MRI evaluation (RESTORE): a prospective multicenter study. Stroke. 2012;43:3278-3283.
14. Manawadu D, Bodla S, Keep J, Jarosz J, Kalra L. An observational study of thrombolysis outcomes in wake-up ischemic stroke patients. Stroke. 2013;44:427-431.
15. Manawadu D, Bodla S, Jarosz J, Keep J, Kalra L. A case-controlled comparison of thrombolysis outcomes between wake-up and known time of onset ischemic stroke patients. Stroke. 2013;44:2226-2231.
16. Natarajan SK, Karmon Y, Snyder KV, Ohta H, Hauck EF, Hopkins LN, et al. Prospective acute ischemic stroke outcomes after endovascular therapy: a real-world experience. World Neurosurg. 2010;74:455-464.
17. Adams HP Jr, Effron MB, Torner J, Dávalos A, Frayne J, Teal P, et al. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II). Stroke. 2008;39:87-99.
18. Adams HP Jr, Leira EC, Torner JC, Barnathan E, Padgett L, Effron MB, et al; AbESTT-II Investigators. Treating patients with 'wake-up' stroke: the experience of the AbESTT-II trial. Stroke. 2008;39:3277-3282.
19. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, et al; ATLANTIS Trials Investigators; ECASS Trials Investigators; NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363:768-774.
20. Wahlgren N, Ahmed N, Dávalos A, Ford GA, Grond M, Hacke W, et al; SITS-MOST Investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet. 2007;369:275-282.
21. Wardlaw JM, Murray V, Berge E, del Zoppo G, Sandercock P, Lindley RL, et al. Recombinant tissue plasminogen activator for acute isch-aemic stroke: an updated systematic review and meta-analysis. Lancet. 2012;379:2364-2372.
22. Thomalla G, Ebinger M, Fiehler J, Fiebach JB, Endres M, Gerloff C. [EU-funded treatment study: WAKE-UP: a randomized, placebo-controlled MRI-based trial of thrombolysis in wake-up stroke]. Nervenarzt. 2012;83:1241-1251.
23. Ma H, Parsons MW, Christensen S, Campbell BC, Churilov L, Connelly A, et al; EXTEND Investigators. A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Defcits (EXTEND). Int J Stroke. 2012;7:74-80.
24. MR WITNESS: a study of intravenous thrombolysis with alteplase in MRI-selected patients. http://www.clinicaltrials.gov/show/NCT01282242. Accessed April 21, 2014.